It is well established that loss of E-cadherin is sufficient to drive anchorage-independence in breast cancer cells in the context of oncogenic modulation of p53 [4] or activation of the PTEN/PI3K/AKT signaling axis [6, 7]. Here, CDH1 is linked to breast carcinoma.